EMAIL THIS PAGE TO A FRIEND

Journal of Pharmacology and Experimental Therapeutics

VX-509 (decernotinib) is a potent and selective janus kinase 3 inhibitor that attenuates inflammation in animal models of autoimmune disease.


PMID 25762693

Abstract

We're sorry this abstract is currently not available.